Truist analyst Jailendra Singh initiated coverage of Iqvia with a Buy rating and $265 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IQV:
- Iqvia price target raised to $263 from $257 at JPMorgan
- Iqvia sees FY23 adjusted EPS $10.26-$10.56, consensus $10.71
- Iqvia reports Q4 adjusted EPS $2.78, consensus $2.76
- Iqvia teams with Alibaba for cloud commercial & clinical solutions in China
- Pharma Industry Could Benefit from Rise in Medicine Spending